Oertel Joachim M K, Baldauf Jörg, Schroeder Henry W S, Gaab Michael R
Department of Neurosurgery, Krankenhaus Nordstadt, Hannover Medical School, Hannover, Germany.
J Neurosurg. 2009 Apr;110(4):792-9. doi: 10.3171/2008.7.JNS0841.
The optimal therapy of arachnoid cysts is controversial. In symptomatic extraventricular arachnoid cysts, fenestration into the basal cisterns is the gold standard. If this is not feasible, shunt placement is frequently performed although another endoscopic option is available.
Between March 1997 and June 2006, 12 endoscopic cystoventriculostomies were performed for the treatment of arachnoid cysts in 11 patients (4 male and 7 female patients, mean age 52 years [range 14-71 years]). All patients were prospectively followed up.
In 11 cases, the arachnoid cysts were frontotemporoparietal and fenestration was performed into the lateral ventricle. In 1 case, the arachnoid cyst was located in the cerebellum and the cyst was fenestrated into the fourth ventricle. Neuronavigational guidance was used in all but 1 case. Endoscopic cystoventriculostomy was performed in all cases without complications. No stents were placed. The mean surgical time was 71 minutes (range 30-110 minutes). The mean follow-up period was 42.7 months (range 19-96 months) per surgical case and 48.8 months (range 19-127 months) per patient. Symptoms improved after 11 of the 12 procedures; 7 of the 11 patients became symptom-free and the others had only mild residual symptoms. The patient who did not experience clinical improvement suffered from depression and demonstrated a significant decrease of the cyst size on the postoperative MR imaging. After 11 of 12 procedures, a decrease in cyst size was observed. In 1 case, a subdural hematoma developed; it required surgical treatment 3 months after surgery. In another case, reclosure of the stoma required repeated endoscopic cystoventriculostomy more than 7 years after the initial procedure.
Overall, endoscopic cystoventriculostomy represents a useful treatment option for patients with paraxial arachnoid cysts in whom a standard cystocisternotomy is not feasible. Based on the results in this case series, stent placement appears not to be required. Despite the long mean follow-up of almost 4 years, however, a longer follow-up period seems to be required before definite conclusions can be drawn.
蛛网膜囊肿的最佳治疗方法存在争议。对于有症状的脑室外蛛网膜囊肿,向基底池造瘘是金标准。若不可行,尽管有另一种内镜治疗选择,但仍常进行分流置管。
1997年3月至2006年6月,对11例患者(4例男性和7例女性,平均年龄52岁[范围14 - 71岁])的蛛网膜囊肿进行了12次内镜下囊肿脑室造瘘术。所有患者均进行前瞻性随访。
11例中,蛛网膜囊肿位于额颞顶叶,向侧脑室造瘘。1例蛛网膜囊肿位于小脑,向第四脑室造瘘。除1例患者外均使用神经导航引导。所有病例均成功进行内镜下囊肿脑室造瘘术,无并发症。未放置支架。平均手术时间为71分钟(范围30 - 110分钟)。每个手术病例的平均随访时间为42.7个月(范围19 - 96个月),每位患者的平均随访时间为48.8个月(范围19 - 127个月)。12例手术中有11例术后症状改善;11例患者中有7例症状消失,其余仅有轻度残留症状。未出现临床改善的患者患有抑郁症,术后磁共振成像显示囊肿大小显著减小。12例手术中有11例术后观察到囊肿大小减小。1例发生硬膜下血肿;术后3个月需要手术治疗。另1例患者,造瘘口重新闭合,在初次手术后7年多需要再次进行内镜下囊肿脑室造瘘术。
总体而言,对于无法进行标准囊肿脑池造瘘术的近轴蛛网膜囊肿患者,内镜下囊肿脑室造瘘术是一种有效的治疗选择。基于本病例系列结果,似乎无需放置支架。然而,尽管平均随访时间接近4年,但在得出明确结论之前似乎需要更长时间的随访。